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Tuberculous and cryptococcal meningitis (TBM and CM) are the most 
common causes of opportunistic meningitis in HIV-infected patients.[1-5] 
TBM and CM share similar clinical and laboratory features, resulting in 
delays to diagnosis and poorer outcomes, particularly in settings where 
confirmatory diagnosis is not possible.[6] Clinical algorithms have been 
proposed to simplify the diagnosis and treatment of these neurological 
infections,[6-8] but a lack of sensitivity and specificity precludes their 
implementation in clinical practice.
The objective of this study was to compare clinical and laboratory 
findings of TBM and CM in HIV-infected patients to propose an 
algorithm to differentiate these diseases.
Methods
We retrospectively analysed data from the clinical records of 108 and 
98 HIV-infected patients with a culture-proven diagnosis of TBM or 
CM, respectively. The patients were admitted between March 1999 
and June 2008 at the Emílio Ribas Institute of Infectious Diseases, 
São Paulo, Brazil. This hospital is a 250-bed tertiary teaching centre 
and the main referral institution for HIV-infected patients in São 
Paulo State. HIV infection was diagnosed by ELISA and confirmed by 
Western blot. We evaluated demographic, clinical, radiological and 
laboratory information. The study was approved by the ethical and 
scientific boards of the institution.
Cerebrospinal fluid (CSF) was obtained by lumbar puncture at hospital 
admission. Pleocytosis was defined as a leukocyte count >5 cells/µL. The 
normal range of lumbar CSF glucose is >2.22 mmol/L (40 mg/dL) and 
CSF protein <0.45 g/L (45 mg/dL). Neutrophil pleocytosis was defined 
as >50% CSF leukocytes.
The comparison between groups (TBM v. CM) was performed 
using the Mann-Whitney U-test for numeric variables and Yates cor-
rected χ2 or Fisher’s exact test as appropriate for categorical variables. 
Odds ratio (OR) and 95% confidence interval (CI) were adjusted 
using a binary logistic regression model (Wald test) and included 
diagnosis of TBM v. CM as the dependent variable. Covariates and 
factors associated with TBM (v. CM) in univariate analysis were 
included to derive a diagnostic index based on clinical, laboratory 
and radiological findings. A receiver operating characteristics (ROC) 
curve was derived to calculate the accuracy of the logistic model. An 
estimation of cut-off for the diagnosis index was made to distinguish 
between TBM and CM. Statistical significance was defined as p<0.05, 
and SPSS 20.0 (IBM Corp., USA) software was used for statistical 
analysis. 
Results
Table 1 shows a comparison of the clinical, radiological and labora-
tory characteristics of HIV-infected patients with TBM and CM. CSF 
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with three abnormal parameters (pleocytosis, 
protein elevation and depressed glucose) was 
observed in 55.6% and 36.1% of patients with 
TBM and CM, respectively (p=0.002). The in-
hospital case-fatality rate was similar between 
the groups (TBM 29% v. CM 29%, p=0.578).
Microscopy was of limited value. Among 
TBM patients, Ziehl-Neelsen staining of CSF 
showed acid-fast bacilli (AFB) in only 
5.5% (6/108) of cases. Among cryptococcal 
patients, India ink staining of CSF showed 
yeast compatible with Cryptococcus spp. in 
84% (82/98) of cases. A cryptococcal antigen 
latex agglutination test of CSF was positive in 
only 82% (80/98) of cases.
Tables 2 and 3 show the results of univari-
ate and multivariate modelling to identify 
variables associated with TBM.
A diagnostic index was derived using a 
multi variate model as follows: 1.635 × (pro-
tein >1.0 g/L) + 1.132 × (Glasgow Coma Scale 
(GCS) <15) ˗ 1.296 × (nausea and vomiting) + 
3.578 × (CSF with polymorphs predominance) 
+ 2.244 × (pleocytosis). 
The parameters in parenthesis were coded 
1 if present or 0 if absent. We excluded the 
value of the constant in the calculation of the 
index. The diagnostic index was a number 
that varied from ˗1.296 to 8.589, and nega-
tive values favoured a diagnosis of CM, while 
positive values favoured a diagnosis of TBM. 
The area under the ROC curve was 0.815 
(95% CI 0.758 - 0.873; p<0.0001). At a cut-off 
of 1.04, sensitivity was 96.0% and specificity 
73.1%. Values >1.04 presented a remarkable 
fall in the level of sensiti vity – a cut-off of 
5.33 presented a specificity of 100% but a 
sensitivity of 34.7% – while values <1.04, 
such as ˗0.73, presented higher sensiti vity 
(100%) but lower specificity (3.2%). Fig. 1 
shows the ROC curve of the logistic model.
Discussion
To the best of our knowledge this is the larg-
est study comparing culture-proven CM and 
TBM in HIV-infected patients. Although 
some clinical and CSF characteristics appear 
useful to the discrimination of these two 
diseases, a diagnostic index could not be 
derived because of a lack of sensitivity and 
specificity, similar to that reported in a pre-
vious study,[6] which derived an area under 
the ROC curve very close to ours in spite 
of the smaller number of patients in the 
groups. A highly accurate logistic model 
did not result in an index with a cut-off suf-
ficiently sensitive and specific to distinguish 
TBM and CM using clinical and laboratory 
features.
In the current study, CSF protein >1.0 g/L, 
GCS <15, absence of nausea and vomiting, 
neutrophil pleocytosis and CSF pleocytosis 
were independently associated with TBM 
diagnosis. There are few studies with a 
hetero geneous design comparing TBM and 
CM. Similar to our findings, GCS <15,[6] 
pleocytosis,[6] and neutrophil pleocytosis[9] 
have been found related to TBM. Fever,[6,10] 
neck stiffness,[6] brain CT abnormalities,[10,11] 
Table 1. Comparison of clinical and laboratory characteristics among 206 HIV-
infected patients with tuberculous or cryptococcal meningitis
Characteristics
Tuberculous 
meningitis, 
n (%) (n=108)
Cryptococcal 
meningitis, 
n (%) (n=98) p-value
Demographic data
Age (years), median (IQR) 36 (30 - 42) 39 (34 - 43) 0.008*
Male sex 78 (72.2) 76 (77.6) 0.520
CD4 (T-cells/mL), median (IQR) (n=183) 65 (30 - 122) 36 (17 - 87) 0.003*
CD4 ≥50 cells/mL 60 (61.2) 30 (35.3) 0.001
Prior HAART use 36 (51.0) 46 (46.9) 0.643
Prior HIV diagnosis 63 (61.2) 95 (96.9) <0.0001*
Clinical data
Fever 84 (77.8) 53 (54.1) 0.001*
Headache 82 (75.9) 87 (88.8) 0.006*
Meningeal signs 20 (19) 11 (11.8) 0.241
Seizures 12 (11.1) 16 (16.3) 0.309
Nausea and vomiting 41 (38.0) 54 (55.1) 0.011*
GCS <15 68 (63.0) 26 (26.5) <0.0001*
Extra-CNS disease 52 (48.2) 50 (51.0) 0.572
Images and laboratory data
Ventricular dilatation on cranial CT 25 (24.8) 9 (10.8) 0.021
Haemoglobin (g/dL), median (IQR) 10.7 (9.4 - 12.0) 11.9 (11.0 - 13.3) 0.004*
CSF characteristics
Leukocytes (cells/mL), median (IQR) 160 (16 - 333) 6 (2 - 64) <0.0001*
Lymphocyte predominance 50/89 (56.2) 48/49 (98.2) <0.0001*
Neutrophil predominance 39/89 (43.8) 1/49 (1.8) <0.0001*
 CSF glucose (mmol/L), median (IQR), 
n=205
1.6 (1.1 - 2.7) 2.1 (1.3 - 2.7) 0.142
 CSF blood glucose ratio, median (IQR), 
n=183
0.3 (0.2 - 0.5) 0.3 (0.2 - 0.5) 0.601
CSF protein, median (IQR), n=205 0.2 (0.1 - 2.9) 0.1 (0.1 - 1.4) <0.0001*
CSF pleocytosis† 89 (82.4) 49 (50.0) <0.0001*
CSF glucose <2.22 mmol/L 68 (63.0) 51 (52.0) 0.157
CSF protein ≥0.45 g/L 97 (90.0) 80 (81.6) 0.185
CSF protein ≥1.0  g/L 77 (71.3) 34 (35.1) <0.0001*
Normal CSF‡ 5 (4.6) 13 (13.4) 0.049*
One CSF abnormal parameter 12 (11.1) 23 (23.7) 0.027*
Two CSF abnormal parameters 31 (28.7) 26 (26.8) 0.641
Three CSF abnormal parameters 60 (55.6) 35 (36.1) 0.002*
Prognosis
In-hospital case fatality rate 31 (28.7) 28 (28.6) 0.578
CNS = central nervous system; CT = computed tomography; IQR = interquartile range; 
HAART = highly active antiretroviral therapy.
*Statistically significant.
†Pleocytosis as ≥5 leukocytes/µL.
‡CSF parameters: ≥5 leukocytes/µL, glucose <2.22 mmol/L and protein ≥0.45 g/L.
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and extrameningeal disease[10] have been 
reported more frequently in TBM in other 
studies than in our study. In these stu-
dies, the variables of headache,[11] vomiting,[11] 
altered sensorium,[11] high opening pres-
sure,[6] low CSF white blood cell count[6] and 
advanced immunosupression[9,11] were more 
frequent in patients with CM. These results 
indicate that some clinical and laboratory 
characteristics seem useful in the differen-
tial diagnosis of TBM and CM; however, in 
clinical practice, they do not usually allow 
for sufficient discrimination between these 
two diseases.
Culture is the mainstay for diagnosis 
of TBM and CM, but alternative tests 
are evolving to provide more rapid and 
reliable diagnosis. In clinical practice, 
the India ink microscopy stain is usu-
ally available for cryptococcal diagnosis in 
resource-limited settings. Yet, in referral 
centres in Africa, India ink has only ~85% 
sensitivity,[12] similar to the sensitivity in 
our study. The use of India ink can be par-
ticularly problematic for early and/or low-
burden infections, with sensitivity only 
40% for quantitative cultures <1 000 colony -
forming U/mL of CSF.[12] Thus, cryptococcal 
antigen (CrAg) tests could be necessary 
in at least 15% of patients with CM and 
negative India ink microscopy. In people 
with AIDS who have a negative India ink 
microscopy, the most common cause of 
meningitis is Cryptococcus in high-burden 
regions.[12] Recently, the World Health 
Organization included the CSF latex CrAg 
agglutination or lateral flow immunochro-
matographic assay (LFA) as the preferred 
diagnostic approach for CM.
In our study, the sensitivity of CSF CrAg 
latex agglutination was only 82%, lower than 
usually reported for this test (93 - 100%).[13] 
CSF CrAg LFA (Immuno-Mycologics, USA) 
has a reported sensitivity of 99.3%, specificity 
of 99.1%, positive predictive value of 99.5% 
and negative predictive value of 98.7%.[12] 
CRAg LFA is a ‘dipstick’ test that requires 
only a drop of CSF and is relatively inexpen-
sive, quick and easy to interpret. Unlike tra-
ditional latex agglutination, CrAg LFA does 
not require laboratory infrastructure or cold-
chain transport.[13]
Unfortunately, rapid diagnosis of TBM 
is more complicated. Detection of AFB in 
patient samples using Ziehl-Neelsen staining 
is widely employed for diagnosis of TBM. 
AFB microscopy is, however, insensitive in 
TBM, with sensitivity rates of <10 - 20%.[14] The 
sensiti vity of AFB microscopy in our study was 
only 5%. The sensitivity of smear micro scopy 
in TBM can be maximised by examination of 
large-volume CSF samples (>6 mL) using sever-
al CSF specimens collected over a few days and 
prolonged slide examination (≥30 min).[15] 
However, these criteria are rarely achieved in 
practice. Recent modifications to the Ziehl-
Neelsen stain have shown optimistic results,[16] 
but replication in other sites is required. Over 
several decades, nucleic acid amplification 
tests (NAATs) of Mycobacterium tuberculosis 
have been evaluated for the diagnosis of 
TBM. A recent systematic review and meta-
analysis of commercial NAATs with a CSF of 
M. tuberculosis culture-positive gold standard 
found a sensitivity of 64% and a specificity 
of 98%.[17] Despite suboptimal sensitivity, the 
rapid turnaround time of NAATs compared 
with culture enhances their role in the early 
accurate diagnosis of TBM. However, NAATs 
Table 3. Multivariate logistic regression model to identify associated variables 
with tuberculous meningitis among 206 HIV-infected patients with tuberculous or 
cryptococcal meningitis
Variable β OR (95% CI) p-value
CSF protein ≥1.0 g/L 1.635 5.13 (1.38 - 19.04) 0.014
GCS <15* 1.132 3.10 (1.03 - 9.34) 0.044
Nausea and vomiting –1.296 0.27 (0.08 - 0.90) 0.033
Neutrophil pleocytosis† 3.578 35.81 (3.80 - 341.30) 0.002
CSF pleocytosis‡ 2.244 9.43 (1.30 - 68.70) 0.027
Constant –4.252
*At admission. 
†Neutrophil pleocytosis defined as >50% CSF leukocytes. 
‡Pleocytosis defined as leukocytes >5 cells/µL.
Table 2. Univariate analysis of associated variables with tuberculous meningitis 
among 206 HIV-infected patients with tuberculous or cryptococcal meningitis
Unadjusted Adjusted*
Variable OR (95% CI) p-value OR (95% CI) p-value 
Male gender 0.81 (0.43 - 1.52) 0.520  
Age <40 years 2.22 (1.24 - 2.96) 0.009
CD4 T-cell count ≥50 cells/µL 2.90 (1.59 - 5.28) 0.001
Previous diagnosis of HIV 0.05 (0.02 - 0.16) <0.0001
GCS <15† 4.50 (2.48 - 8.19) <0.0001 3.10 (1.03 - 9.34) 0.044
Fever 2.84 (1.55 - 5.19) 0.001
Headache 0.33 (0.15 - 0.73) 0.006
Triad of meningism, fever and 
headache
2.49 (0.96 - 6.46) 0.072
Nausea and vomiting 0.48 (0.27 - 0.83) 0.011 0.27 (0.08 - 0.90) 0.033
Haemoglobin <10 g/dL 2.92 (1.53 - 5.57) 0.001
CSF pleocytosis‡ 4.68 (2.49 - 8.79) <0.0001 9.43 (1.30 - 68.70) 0.027
CSF neutrophil predominance 32.9 (5.6 - 195.4) <0.0001 35.81(3.80 - 341.30) 0.002
CSF protein ≥1.0 g/L 4.60 (2.56 - 8.28) <0.0001 5.13 (1.38 - 9.04) 0.032
Normal CSF protein, glucose 
and leukocytes
0.31 (0.11 - 0.88) 0.049
Abnormal CSF protein, 
glucose and leukocytes
2.21 (1.27 - 3.88) 0.008
Ventricular dilatation on 
cranial CT
2.71 (1.20 - 6.08) 0.021
Brain atrophy on cranial CT 0.35 (0.15 - 0.78) 0.015
*Adjusted OR was measured by binary logistic regression model (Wald test) and included baseline fever, headache, T-cell
  CD4 count, CSF protein, GCS at admission, nausea and vomiting, pleocytosis and CSF neutrophil pleocytosis.
†At admission.
‡Pleocytosis defined as ≥5 leukocytes/µL. 
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are unavailable for most resource-limited laboratories. Yet, the avail-
ability of automated NAATs via the GeneXpert system (Cepheid, USA) 
is increasing, but testing a large volume of centrifuged CSF remains 
essential.
In terms of the current status of meningitis diagnosis in HIV-
infected patients, we would recommend a cryptococcal antigen assay 
(ideally LFA) as an initial approach.[18] Following a negative test in an 
adequate clinical and CSF context, empiric treatment for TBM should 
strongly be considered. However, it is important to consider bacteria 
(e.g. Streptococcus pneumoniae, Neisseria meningitidis, Listeria mono­
cytogenes) and syphilitic meningitis in the differential diagnosis of 
meningitis in HIV-infected patients. More-rare aetiologies include 
other fungal pathogens (i.e. Histoplasma capsulatum, Candida, Cocci­
dioides) and viruses (i.e. herpes virus, enterovirus).[19,20]
This study has limitations. We did not have CSF opening pressure 
available for the whole population. We included only culture-proven 
cases and not culture-negative cases, tested with techniques such 
as NAAT. Therefore, we did not compare clinical and laboratory 
differences between culture-positive and culture-negative cases. 
However, we did include a reasonable number of cases, all of which 
were culture proven, allowing rigorous case definition.
In conclusion, although some clinical and basic CSF characteristics 
appear useful in the differential diagnosis of TBM and CM in HIV-
infected patients, an accurate algorithm was not identified. In this sce-
nario, optimised access to more rapid, sensitive and specific laboratory 
tests is essential.
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Fig. 1. Logistic regression model ROC curve for HIV­infected patients with 
TBM or CM. Area under the curve was 0.815 (95% CI 0.758 ­ 0.873), 
p<0.0001. At a cut­off of 1.04, sensitivity was 96.0% and specificity 73.1%.
